These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25479177)

  • 1. Progress toward a vaccine for Middle-Eastern respiratory syndrome.
    Woodland DL
    Viral Immunol; 2014 Dec; 27(10):483. PubMed ID: 25479177
    [No Abstract]   [Full Text] [Related]  

  • 2. MERS vaccine is technically feasible, but is it commerically feasible?
    Riedmann EM
    Hum Vaccin Immunother; 2014; 10(6):1429-30. PubMed ID: 25396231
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccines for the prevention against the threat of MERS-CoV.
    Du L; Tai W; Zhou Y; Jiang S
    Expert Rev Vaccines; 2016 Sep; 15(9):1123-34. PubMed ID: 26985862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel Research Progress of the Recombinant Vaccine for MERS-CoV].
    Hu H; Shen Y
    Bing Du Xue Bao; 2016 Jul; 32(4):495-500. PubMed ID: 29995374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current Status of Middle East Respiratory Syndrome Vaccines].
    Fan Y; Jiang Z; Li P; Den Y; Huang J; Zhu L; Xu Z
    Bing Du Xue Bao; 2016 Nov; 32(6):825-9. PubMed ID: 30004658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INFECTIOUS DISEASE. Camel vaccine offers hope to stop MERS.
    Kupferschmidt K
    Science; 2015 Dec; 350(6267):1453. PubMed ID: 26680169
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.
    Maslow JN
    Hum Vaccin Immunother; 2017 Dec; 13(12):2918-2930. PubMed ID: 28846484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus.
    Lan J; Deng Y; Song J; Huang B; Wang W; Tan W
    Virol Sin; 2018 Oct; 33(5):453-455. PubMed ID: 30374826
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of protection against coronavirus induced diseases. A review.
    Enjuanes L; Smerdou C; Castilla J; Antón IM; Torres JM; Sola I; Golvano J; Sánchez JM; Pintado B
    Adv Exp Med Biol; 1995; 380():197-211. PubMed ID: 8830481
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology.
    Gilbert SC; Warimwe GM
    Vaccine; 2017 Aug; 35(35 Pt A):4461-4464. PubMed ID: 28576573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing the MERS coronavirus threat.
    Haagmans BL; Osterhaus AD
    Sci Transl Med; 2014 May; 6(235):235fs19. PubMed ID: 24807556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine against Middle East respiratory syndrome coronavirus.
    Zumla A; Memish ZA; Hui DS; Perlman S
    Lancet Infect Dis; 2019 Oct; 19(10):1054-1055. PubMed ID: 31559955
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccine against Middle East respiratory syndrome coronavirus.
    Shen X; Sabir JSM; Irwin DM; Shen Y
    Lancet Infect Dis; 2019 Oct; 19(10):1053-1054. PubMed ID: 31559953
    [No Abstract]   [Full Text] [Related]  

  • 14. Chikungunya virus vaccines: Current strategies and prospects for developing plant-made vaccines.
    Salazar-González JA; Angulo C; Rosales-Mendoza S
    Vaccine; 2015 Jul; 33(31):3650-8. PubMed ID: 26073010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Middle East respiratory syndrome: obstacles and prospects for vaccine development.
    Papaneri AB; Johnson RF; Wada J; Bollinger L; Jahrling PB; Kuhn JH
    Expert Rev Vaccines; 2015 Jul; 14(7):949-62. PubMed ID: 25864502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First clinical trial of a MERS coronavirus DNA vaccine.
    Yoon IK; Kim JH
    Lancet Infect Dis; 2019 Sep; 19(9):924-925. PubMed ID: 31351923
    [No Abstract]   [Full Text] [Related]  

  • 17. Plant-based vaccines against respiratory diseases: current status and future prospects.
    Márquez-Escobar VA; Rosales-Mendoza S; Beltrán-López JI; González-Ortega O
    Expert Rev Vaccines; 2017 Feb; 16(2):137-149. PubMed ID: 27599605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BacMam virus-based surface display of the infectious bronchitis virus (IBV) S1 glycoprotein confers strong protection against virulent IBV challenge in chickens.
    Zhang J; Chen XW; Tong TZ; Ye Y; Liao M; Fan HY
    Vaccine; 2014 Feb; 32(6):664-70. PubMed ID: 24342247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [AIDS vaccines: an enigma in vaccine development].
    Dorner F; Barrett N
    Wien Klin Wochenschr; 1990 Jan; 102(2):51-8. PubMed ID: 1689919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and immunogenicity of recombinant GapA(+) Mycoplasma gallisepticum vaccine strain ts-11 expressing infectious bronchitis virus-S1 glycoprotein and chicken interleukin-6.
    Shil PK; Kanci A; Browning GF; Markham PF
    Vaccine; 2011 Apr; 29(17):3197-205. PubMed ID: 21354248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.